Isolated hepatic nuclei from euthyroid rats were incubated with tracer (125I)Ltriiodothyronine (T3) and increasing doses of nonradioactive T3 for 30 min at 37degrees C. The T3 bound specifically to nuclear sites increased with increasing T3 doses to a plateau, which represented the nuclear binding capacity, M. Addition of 1 mM KCN, NaF, dinitrophenol, oriodoacetate did not affect nuclear binding, indicating that active metabolism was not required. Kinetic studies showed that the nuclear sites were equilibrated with T3 within 30 min of incubation (one-half maximal binding at 3 min) and that the rate of release of T3 in vitro (0.058 min-1) was the same for endogenous T3 or for T3 bound to nuclei in vitro. Nuclear T3 resisted extraction with 0.14 M NaC1 buffered at pH 7.5, but both endogenous hormone and T3 bound in vitro were readily extracted by 0.4 M KC1 at pH 8.0. The elution profiles of endogenous and in vitro-bound T3 from Sephadex G-100 columns showed a common protein peak with a molecular weight of 60-65,000, assuming a globular protein. Scatchard analysis of in vitro displacement studies showed a single class of binding sites. Mean M equals 0.23 times 10-9 M or 0.85 ng T3 for nuclei isolated from 1 g of liver. Mean M closely corresponded to that anticipated from reported in vivo studies. The
INTRODUCTION
Using in vivo displacement techniques, we have demonstrated the presence of limited-capacity binding sites for L-triiodothyronine (Ts)1 in the nuclei of rat liver and kidney (1) . Ta bound to hepatic nuclear sites exchanged rapidly with Ts in the cell cytosol (2) . These techniques thus allowed measurement of the nuclear binding capacity (M) for Ta as well as the apparent association constant of the hepatic nuclear sites. Several lines of evidence suggest that the nuclear sites represent the cellular receptors for thyroid hormones and that binding of Ta to these sites is a prerequisite for the expression of hormonal activity: First, the nuclear sites appeared relatively specific for Ta, since L-thyroxine (Tt) was bound to a much lesser degree. The apparent association constant (K.) of the nuclear sites for Ta, 4.7 X 10i M', was estimated to be about 20-fold greater than that of T. (2) . Second, in vivo competition studies of various analogues of iodotyrosines and iodothyronines and of Ta for the nuclear sites of both liver and heart showed that when analogue distribution and metabolism were considered, the displacement activities of the analogues were closely correlated with their reported thyromimetic activities (3) . Third, examination of T8 binding to nuclei of a number of rat tissues showed limitedcapacity sites with K. similar to that of liver in all tissues studied (4) . Moreover, there was a good correlation between tissue M and its reported biological response to thyroid hormones. For example, the M of spleen and testis, tissues considered unresponsive to thyroid hormones, were substantially less than those of liver, kidney, heart, and anterior pituitary. Fourth, studies of the intranuclear distribution of Ts showed that the limited-capacity binding sites were localized to the chromatin fraction (5) . The binding sites were further characterized as chromatin-associated nonhistone proteins. The identification of the Ts nuclear receptors as nonhistone chromatin proteins is of special interest, since this class of nuclear proteins is considered intimately related to the control of DNA transcription (6) . Moreover, some of the earliest detectable cellular biochemical changes that follow Ts administration are the augmentations in DNA-dependent RNA polymerase activity and the rate of nuclear RNA synthesis (7) .
These observations have been confirmed in part by DeGroot and Strausser (8) in rat studies, and Samuels and Tsai have demonstrated limited binding capacity nuclear sites for iodothyronines in pituitary GH1 cells in tissue culture (9) and in intact lymphocytes (10) .
More recently, we have demonstrated limitedcapacity, high-affinity binding of Ts to isolated rat liver nuclei in vitro (11) . Binding of Ta to limited-capacity nuclear sites in vitro has been separately reported by Samuels and Tsai (9, 12) . Our preliminary observations have indicated that the nuclear sites demonstrated in vitro have similar characteristics to those previously described in in vivo studies (2, 3) . The present report describes the kinetics of binding and the extraction properties of Ta bound to the nuclear receptor sites in vitro. In addition, data are presented that suggest that cytosol proteins are not required to effect the translocation of Ts from cytosol to the nucleus.
METHODS
Male Sprague-Dawley rats, weighing between 150-200 g, were obtained from Carworth Div., Becton, Dickinson & Co., New City, N. Y., and maintained on a Wayne Laboratory rat diet (Allied Mills, Inc., Chicago, Ill.) (1 Fg iodine/g) and tap water ad lib. In several experiments athyreotic animals were used. Surgical thyroidectomy was performed by the supplier. On receipt in the laboratory, thyroidectomized animals were placed on Low Iodine Test Diet fortified with vitamins (Nutritional Biochemical Corporation, Cleveland, Ohio) for 2 wk and then injected i.p.
with 100 /ACi of [I]sodium iodide. Body weight was measured twice a week, and the animals were considered athyreotic only after their body weights had remained constant for 3 wk. The serum Ts concentration of these rats was undetectable (less than 2 ng/100 ml) as measured by radioimmunoassay (13) .
Methods for the preparation of the nuclei have been detailed in previous reports (2, 14) . After centrifugation through 2.2 M sucrose and 3 mM MgCl2, the nuclear pellet obtained contained highly purified nuclei, as demonstrated by electron microscopy (average protein/DNA ratio was 1.84; average RNA/DNA ratio was 0.36). The nuclei were resuspended in 4 ml of 0.32 M sucrose and 3 mM MgC12, so that 1 ml of the nuclear suspension contained nuclei recovered from 1 g of liver. These nuclear suspensions were called unwashed nuclei.
Nuclei were further purified in several experiments to remove the small amount of cytosol protein (see Results) that might contaminate the nuclear pellet. The resuspended nuclei were centrifuged at 700 g for 10 min. The pellet was again suspended in 4 ml 0.32 M sucrose and 3 mM MgC12 and centrifuged at 700 g for 10 min. This procedure was carried out once more, and the resulting nuclei were suspended in 4 ml 0.32 M sucrose and 1 mM MgC12 (nuclei recovered from 1 g liver per ml). These preparations were called washed nuclei. Cytosol was obtained by centrifugation of the initial 700 g supernate at 130,000 g for 60 min in a Spinco 40 angle rotor (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif. rate of the nuclear pellet was determined in a Packard Autogamma Spectrometer (Packard Instrument Co., Inc., Downer's Grove, Ill.). Sufficient counts were accumulated to limit counting error to less than ±5%. Measurements of the percent of incubated ["5I]Ts bound to the Triton X-100treated nuclei were performed in triplicate at each dose of Ts incubated. After incubation with ['I]Ts, the nuclei were pelleted by centrifugation for 10 min at 10,000 g and then suspended by gentle homogenization into 2 ml of the indicated salt solutions. After 30 min at 0°C, the nuclei were pelleted by centrifugation at 10,000 g for 5 min. The supernate was removed and the nature of the radioactivity was examined by Sephadex gel filtration. Two different-sized columns were employed. To determine whether the extracted ['I]-Ta was protein-bound or free hormone, 0.5 ml of the 0.14 M NaCl or the 0.4 M KC1 extracts were applied to 5 ml Sephadex G-50 medium columns (1.2 X 5.5-cm) equilibrated with the same buffer used for extraction. 1-ml fractions were collected. Protein-bound ["6I]Ts, eluted at the void volume, and nonprotein-bound [(I]Ts was recovered somewhat after the total column volume. Recovery of the applied radioactivity was 80-110%. The 0.4 M KC1 extracts were studied further by filtration on large columns of Sephadex G-100. The columns (100 X 1.3-cm) with a total vol of 90-100 ml were packed with Sephadex G-100 equilibrated with 0.4 M KC1, 0.01 M Tris, 0.001 M EDTA, and 0.1%o sodium azide, pH 8.0, and then washed extensively with the same buffer. 0.5-1 ml of the nuclear 0.4 M KC1 extracts were applied. The flow rate was maintained at 15 ml/h. Fractions of 1.3 ml were collected, and the elution profile of radioactivity was compared to that of dextran blue (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) and proteins with known molecular weights (Schwarz/ Mann Div., Becton, Dickinson & Co., Orangeburg, N. Y.).
Analytical procedures were as follows: DNA was determined by the method of Burton (15) with calf thymus DNA (Sigma Chemical Co.) as a standard; proteins were mea-sured by the method of Lowry, Rosebrough, Farr, and Randall (16) , with bovine serum albumin as a standard. Equilibrium dialysis was carried out as described previously (17) . The nature of the radioactivity in various preparations was assessed by paper chromatography on Whatman 3 MM paper in a tert-amyl alcohol: 2 N NH4 OH: hexane solvent system. Details of the methods are reported elsewhere (18) .
RESULTS
Characteristics of the in vitro incubation system. After incubation of isolated liver nuclei with tracer [I]Ts plotted as a function of the total Ts in the incubation mixture ( Fig. 2 ), Ts bound specifically to nuclear sites approaches a plateau that represents the binding capacity, M, of the nuclear sites. Thus, as in previously reported in vivo studies (2) , the binding of Ts to isolated nuclei in vitro is characterized by a well-defined binding capacity.
To examine further the characteristics of binding of Ts to isolated nuclei, experiments were first carried out to study the stability of the in vitro system. Fig. 3 shows a time course of nuclear Ts binding after incubation of both tracer (1 pmol/ml) and a molar excess ( The possibility that the modest decrease in specific nuclear binding with increasing time of incubation was due to a requirement for active metabolism and that essential metabolic substrates might be depleted during prolonged incubation appeared to be excluded, since addition of different metabolic inhibitors did not affect nuclear Ts binding significantly (Table I ). Since the cause of the moderate decrease in nuclear binding during prolonged incubation was not determined, the duration of incubation in all subsequent studies was limited to 30 min.
To determine whether specific binding was proportional to the number of nuclear sites in the incubation mixture, increasing volumes of the nuclear suspension were incubated with either tracer or a molar excess of [UI]Ts ( Fig. 4 ). An increase in the percentage of Fig. 3 with an increasing concentration of hepatic nuclei (from 0.1 to 0.4 ml suspension of isolated nuclei) equivalent to nuclei harvested from 0.1 to 0.4 g liver in 1 ml incubation medium. Specific nuclear binding is proportional to the nuclear concentration.
The release rate of Ts bound to nuclear sites was determined both for endogenous hormone and for Ta bound during incubation in vitro ( Fig. 5) . A tracer dose of ['I]Ts (5 ng/100 g body wt) was injected i.v. 30 min before the animals were killed. During this interval the specific nuclear sites are maximally labeled in vivo (2) .
Nuclei were then harvested and incubated with tracer [tI]Ts (1 pmol/ml). Incubation mixtures were sampled at 2-min intervals to determine specific nuclear binding. At 9.5 min of incubation, the mixtures were divided. A molar excess of Ts (3,000 pmol/ml) was added to one portion to prevent detectable further nuclear binding of ['I]Ts from the incubation medium, and the vehicle in which the loading dose was dissolved was added to the other portion. The curves in Fig. 5 show that the release rate of nuclear Ts was the same for endogenous Ts (ti = 14.0 min) as for Ta bound to specific nuclear sites in vitro (ti = 14.5 min). The lack of significant change in the maximal percentage of [PI]Ts bound specifically in vitro when vehicle was added indicated that the vehicle did not perturb the system. In two other experiments, similarly designed, the ti of release of nuclear Ts was 10.0 and 12.2 min. The similarity in the rates of release in vitro of Ta bound to the nuclear sites in vivo and in vitro provides further evidence that Tx binding to isolated nuclei occurs at the same sites as previously reported in studies in vivo.
The average ti of 12 min for Ts bound to nuclear sites also allows estimation of the effect of endogenous Ts released from the nuclei upon subsequent calculations.
As determined by in vivo displacement studies (4), the mean M is 1.77 ng Ta for nuclei derived from 1 g of liver (2.72 pmol/g). In euthyroid rats, the mean percentage saturation of these sites is 47% (4), and the mean recovery of nuclei based on DNA measurements is 59%. Thus, the nuclear suspensions used in these studies contain approximately 0.151 pmol Ts/0.2 g liver nuclei (2.72 X 0.47 x 0.58 X 0.2). Based on the observed release rates, the main portion (82%) of the endogenous Ts will be released from the nuclei during 30 min of incubation. Since 1 pmol/ml of ["I]Ts is the lowest concentration of Ts incubated in vitro, the released endogenous Ts will augment by 15% the medium hormone concentration at tracer ['I]Ta levels and will make a progressively smaller contribution to the Ts concentration when increasing doses of hormone are incubated. The resulting change in the calculation of bound Ts is so small that it is within the error of determination of specific Ts binding. Thus, the contribution of endogenous Ts to total incubated hormone concentration has been discounted in subsequent calculations. 
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Additionally, since an average of 47% of the nuclear sites are occupied under endogenous conditions, calculations based on the observed release rate of nuclear Ts indicate that 80-95% of the nuclear sites will be accessible for hormone binding in vitro during a 30-min incubation. Thus, the nuclear binding capacity determined in vitro should reflect adequately that measured in vivo.
Characterization of Ta bound to isolated nuclei. Chromatographic studies were performed to determine the nature of the Ts bound to isolated nuclei for comparison to previously reported data when nuclei were labeled with radioactive T3 in vivo (5) . Rats were injected with [`I]Ta i.v., 50 ng/100 g body wt, 30 min before they were killed. Nuclei were harvested and incubated either with a low dose (1 pmol/ml) or a molar excess (3,000 pmol/ml) ['6I]Ts in vitro for 10 min at 370C. After incubation, one portion was taken for measurement of total nuclear Ts radioactivity and another was treated with Triton X-100, 0.5% in 0.32 M sucrose and 3 mM MgCl2.
Pelleted nuclei from a third and fourth portion were treated separately with buffered 0.14 M NaCI or 0.4 M KCl. As indicated in Table II, The nuclear radioactivity in the 0.4 M KCI extracts, the 0.14 M NaCl extracts, the unextracted nuclei, and the Triton X-100-treated nuclei was shown to be authentic Ts by paper chromatographic procedures.
Since an appreciable amount (37%) of the ['tI]Ts bound to specific nuclei sites in vitro was recovered as protein-bound hormone, this extract was analyzed in greater detail on a Sephadex G-100 column (Fig. 7) . The [SI]Ts incorporated in vivo showed an elution profile virtually identical to that reported previously (5) .
The large peak of radioactivity observed at the void volume could represent either Ta protein complex still in association with DNA or aggregates of the Ta nucleoprotein complex. A second peak observed at tube 29 is Ts bound to nucleoprotein. If its structure is globular, the molecular weight of this protein, determined by comparison to the elution profiles of marker proteins with known molecular weights, was 60-65,000, as observed previously (5) . The remainder of the radioactivity eluted after tube 100 and represented free hormone. An almost identical elution profile was observed for the ['I]Ta bound to nuclear sites in vitro. The distribution of radioactivity among the peaks was somewhat different, however, with a greater fraction of radioactivity appearing as free hormone. This is probably due to the fact that treatment with 0.4 M KCI extracts some ['I]Ts bound nonspecifically as well as that bound to specific sites during in vitro incubation (Table II) . This would not occur when the nuclear sites were labeled in vivo, since only 10% of the nuclear Ta is bound nonspecifically after injection of a tracer dose of Ts (1, 2) . The virtual identity of the elution profiles of in vivo and in vitro-bound nuclear Ts suggests that Ts is bound by isolated nuclei to the same chromatin-associated nonhistone protein as previously shown for endogenous Ts in vivo (5) .
Apparent equilibrium assoication constant and binding capacity. After it was established that equilibrium conditions prevailed when nuclei were incubated at 370C for 30 min, displacement studies, as depicted in Fig. 1 , were plotted according to Scatchard to determine the apparent K. for the specific nuclear sites and Ts, and the nuclear binding capacity (M) (Fig. 8) . These plots revealed a single class of specific nuclear binding sites for Ts. In the illustrated experiment, carried out with unwashed nuclei incubated in the presence of 0.3% HSA, K. = 4.28 X 10' M-1. Mean K. for 13 studies ' performed under these conditions was 5.55 X 10' M1 (range = 1.9 -12.3 X 108 M-1) ( Table III) . The possibility that another class of binding sites with a higher affinity for Ta might have been overlooked is unlikely, since no siga Most of these determinations were performed in the course of other investigations. nificant change in K. or M was noted in several studies in which the tracer dose of [I]Ts was reduced to 0.1 or 0.01 pmol/ml. HSA was employed to insure solubility of the higher doses of Ts in the incubation medium. Since it was possible, however, that the added 0.3% HSA might extensively bind the Ta in the incubation buffer, the free Ts concentration in the incubation buffer might be overestimated, and the calculated K. from Scatchard plots underestimated. This possibility was considered unlikely, since the K. was not significantly different from the K. of the 0.3% HSA incubation in studies in which either unwashed nuclei were incubated in buffer supplemented by a 10-fold lower HSA concentration (0.03%) or washed nuclei were incubated in buffer without addition of exogenous protein (Table  III) . The degree of protein binding of Ta was also studied by equilibrium dialysis. The dialysis fraction of incubation buffer with tracer [I]Ta supplemented with 0.3% HSA was 0.84, and that of 0.3% HSA alone was 0.87. These studies showed that, at most, only 16% of Ta in the incubation medium could be protein-bound. Thus, K. determined by these methods was not significantly influenced by protein binding of Ta in the incubation medium.
The Scatchard plots of these incubations also enabled estimation of the M of the nuclear sites for Ta. Mean M for 19 experiments a was 0.23 X 10' M (Table III) and was equivalent to 0.3-0.5 ng Ts/mg DNA. The Ts M determined in these experiments was in good agreement with that anticipated for the nuclear receptor sites from measurements of M in in vivo displacement studies (4). The mean M in in vivo studies is 1.77 ng Ta for nuclei derived from 1 g liver (range= 1.02-2.35 ng/g). Since the mean recovery of hepatic nuclei isolated by centrifugation through 2.2 M sucrose is 59%,a a mean M of 1.04 ng Ta/g liver nuclei (range = 0.60 -1.37 ng Ta/g) would be anticipated in vitro. Mean M isolated was 0.85 ng Ta/g isolated liver nuclei (range = 0.46 -1.30 ng) for all experimental conditions. The modest reduction in binding capacity in washed nuclei may result from a small decrease in the recovery of nuclei during the washing procedures. The agreement in M determined in vitro with that predicted from measurements in vivo provides further evidence that the nuclear Ta binding site studied in vitro is probably the same as in the intact animal.
Role of cytosol protein. A significant role for specific cytosol proteins in effecting the translocation of Ta from the incubation medium to the nuclear receptor site was considered unlikely, since nuclear binding of Ts to sites quantitatively and physicochemically similar to those ' The mean 59% recovery of hepatic nuclei was determined in in vivo studies (4). A similar recovery was found in the present studies based on DNA measurements of the liver homogenate and isolated nuclei. Nevertheless, the possibility existed that a small amount of cytosol protein contaminating the isolated nuclear pellet might be critical for nuclear binding in vitro. In a representative experiment, the total protein content of hepatic nuclei recovered from 0.2 g liver was 1.780 mg. After suspension in 1 ml incubation medium, nearly 10% of the nuclear protein, 0.166 mg, was found in the medium as soluble protein. The nuclear protein at the start of incubation was 1.614 mg (1.780-0.166). After a 30-min incubation at 370C, the protein content of the incubation medium increased to 0.212 mg. Thus, only 0.046 mg or 2.8% [(0.212 -0.166)/1.614] X 100 of the initial nuclear protein was released during incubation. We considered, therefore, that the major portion of the protein found in the incubation medium at the start of incubation might be cytosol protein contaminating the nuclear pellet. The potential role of such cytosol contamination in nuclear binding was assessed in experiments employing nuclei extensively washed before incubation. In one study, K. of nuclei incubated in buffer alone was 1.5 X 10' M-1. Addition of the protein recovered from the supernate of the nuclear washes ("contaminating cytosol") at a concentration of 0.11 mg/ml did not result in any change in K.. Similar results were obtained for nuclei incubated with or without washing after a 30-min preincubation at 370C. In a divided, one portion being extensively washed and the other simply resuspended in incubation medium containing contaminating cytosol protein. The K. was 6.2 X 10' M-1 and 8.0 X 10' M-1 and M was 0.16 X 10' M and 0.14 x 10-' M, respectively. Thus no significant changes in nuclear binding resulted from extensive washing. Since nuclei isolated from euthyroid rats were used in all of these studies, it remained possible that endogenous Ts bound to specific cytosol proteins required for translocation of T8 to the nuclei receptor site were already present within the nuclei at the start of incubation. These proteins might then be released into the medium during incubation, bind exogenous Ta, and transport the hormone back into the nucleus to the receptor site in vitro. If this formulation were correct, it would not be possible to demonstrate specific nuclear binding in vitro when nuclei isolated from athyreotic rats were used. In such nuclei there is no Ta bound to the nuclear receptor site at the beginning of incubation. Fig. 9 illustrates a Scatchard plot of an in vitro displacement study employing nuclei obtained from athyreotic rats. The calculated K. and M are in the range of these parameters measured in nuclei from euthyroid animals (Table III ). In the study illustrated, the K. was 4.27 X 10' M-1, and M was 0.35 X 10' M (1.14 ng/g liver nuclei). Thus, the demonstration of specific binding of T3 by isolated nuclei from athyreotic rats suggests that the existence of intranuclear cystosol protein that facilitates Ta translocation is unlikely. logical events in the intact animal, a i current studies has been to assess th binding to nuclei in vitro to nuclear l nous Ts in vivo (1, 2 ported previously both in intact animals (3) and in the in vitro incubation system (11) .
major focus of the The only difference observed between Ts binding by le relevance of Ts nuclei in vitro and Ts binding in vivo is that the binding binding of endogeaffinity of the nuclear sites was substantially lower the initial demon-(1,000-fold) in vitro than in the living animal (2) . The ited-capacity highcurrent studies show that specific nuclear binding in (11, 12) , considervitro does not depend on active metabolic processes, a whether nuclear since T8 binding was unaffected by addition of different e same site as en-metabolic inhibitors. The difference in binding affinity, e lines of evidence therefore, probably results from conditions of incubairst, the concentration of the isolated nuclei vastly different from the intro, 0.23 X 10-M, tracellular milieu. In this regard, a sixfold decrease in le concentration of binding affinity but no change in total sites has been vivo (2, 4) , when reported by Samuels and Tsai (12) for Ts binding by ring the isolation nuclei isolated from cultured pituitary GH1 cells and rat reported in sepaliver, compared to Ta binding by nuclei in intact GH1 ). From published cells and human lymphocytes (10) . Thus, the bulk of a3binding capacity evidence indicates that in vitro binding of Ts occurs at )1.37) for nuclei the same chromatin protein site as endogenous hor-Ta/mg DNA. The mone. The ability to study nuclear-Ta interactions in esent studies was vitro should facilitate a detailed analysis of this process. ,er nuclei (0.30 -Although it is clear that the Ts receptor is a chronificantly different nicndto th fferenula matin-associated nonhistone protein, which can be demind to the nuclear m eled in vivo were onstrated both in vivo and in vitro, the mechanism by 3ame rate in vitro which Ta enters the nucleus from the cytosol and binds ding indicate that to the receptor remains obscure. The present studies not conform to a show that active metabolic processes are not required ulation of the rate for binding to nuclear sites. That the translocation of 58 M. I. Surks, D. H. Koerner, and 1. H. Oppenheimer steroid hormones to chromatin receptor sites appears to require initial binding to specific cytosol proteins, which are translocated into the nucleus and bind to the chromatin, raises the question whether analogous events obtain for Ts. Cytosol proteins that bind both Ta and L-thyroxine have been reported previously from a number of laboratories (19) (20) (21) (22) (23) , but the role of these proteins in effecting the translocation of Ts to the nucleus was not studied by these investigators. Recently, however, Dillman, Surks, and Oppenheimer (24) have compared the quantitative aspects of binding of Ts and iodothyronine analogues by cytosol proteins to those of the nuclear receptor sites. Although a class of limitedcapacity, high-affinity binding sites for Ts was demonstrated in the cytosol, marked differences were observed between these sites and those of the nuclear receptor. The apparent association constant for cytosol Ts binding sites was approximately 1/200th that of the nucleus, and the binding capacity of the cytosol Ta binding sites was nearly 250 times that of the nuclear sites. Moreover, less than 1% of the cytosol sites were saturated, compared to 47% saturation of nuclear sites at euthyroid endogenous Ts concentrations (4) . Furthermore, the spectrum of binding affinities of the cytosol sites for Ts analogues was grossly different from that of the nuclear receptor. Thus, unless radical changes occur in the quantitative and qualitative binding characteristics of cytosol proteins upon entry into the nucleus, these major differences between cytosol protein and nuclear receptor binding of Ta suggested that an interaction between Ts and specific cytosol proteins was not a prerequisite for binding of Ts to the nuclear receptor. The present studies, which demonstrate that Ta is translocated in vitro from an aqueous medium to nuclear sites that are qualitatively and quantitatively similar to the nuclear receptor sites of the intact rat, strongly support this conclusion. Addition of small amounts of cytosol protein did not enhance translocation of Ta into the nucleus. In contrast, incubation of isolated nuclei directly in cytosol decreased nuclear binding (11) . Finally, the possibility was tested that intranuclear Ts bound to a specific cytosol protein was already present in the isolated nuclei and then acted like a shuttle, binding hormone at the nuclear membrane and transporting it to the chromatin receptor. This possibility appears quite unlikely since the Ta binding characteristics in vitro for nuclei obtained from athyreotic rats were similar in all respects to those obtained from euthyroid animals.
Thus, in contrast to steroid hormones, Ts does not appear to require an initial interaction with a specific cytosol protein to effect translocation into the nucleus. A different provisional model for nuclear Ts binding may then be proposed. Ts bound to plasma proteins exchanges rapidly with cytosol proteins and cellular or-ganelles. Once in the cell, bound Ts readily dissociates and either returns to the plasma compartment or may be translocated into the nucleus as free hormone with subsequent binding to the chromatin nonhistone receptor. Binding to the receptor may then result in an increased rate of transcription of DNA or the transcription of new DNA loci, which eventuate in the expression of hormone action.
